Literature DB >> 6580896

Bromo-DMA: the Australasian hallucinogen?

N Buhrich, G Morris, G Cook.   

Abstract

If the frequency of seizures by police of hallucinogens reflects the frequency with which various hallucinogens are ingested in Australasia, most toxic states resulting from hallucinogen abuse are due to Bromo-DMA and not to LSD as is commonly reported by the subjects. Two cases of intoxication with the new hallucinogen, Bromo-DMA, are reported. Both recovered within 24 hours following treatment with haloperidol.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6580896     DOI: 10.3109/00048678309161284

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  2 in total

Review 1.  'Designer drugs'. A problem in clinical toxicology.

Authors:  J F Buchanan; C R Brown
Journal:  Med Toxicol Adverse Drug Exp       Date:  1988 Jan-Dec

2.  The Non-Peptide Arginine-Vasopressin v1a Selective Receptor Antagonist, SR49059, Blocks the Rewarding, Prosocial, and Anxiolytic Effects of 3,4-Methylenedioxymethamphetamine and Its Derivatives in Zebra Fish.

Authors:  Luisa Ponzoni; Daniela Braida; Gianpietro Bondiolotti; Mariaelvina Sala
Journal:  Front Psychiatry       Date:  2017-08-14       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.